Consumers have grown accustomed to personal and wearable electronics, including personal wellness monitors like step trackers. Building on this trend, the medical market is innovating wearables that monitor vitals and health conditions. Continued advances in the technology have made it possible for such devices to effectively diagnose conditions and apply therapies, which can produce more positive outcomes and improve millions of lives.
Digital drug delivery devices are one of the targets of medical wearable development. They illustrate the promise of therapeutic wearables by delivering real-time dosage adjustments, thus reducing the risk of over- or under-medication. For example, low-profile, flexible drug-delivery patches have been developed with smart electronics that administer medicines, such as a continuous glucose monitor on a patient’s arm that sends signals to activate their insulin pump. Wearables could also be used to administer pain management, chemotherapy, antiviral medications and immunosuppressants.
These devices can make treatment more convenient for patients, improving medication compliance and, ultimately, outcomes. In a recent Molex survey of pharmaceutical professionals from companies with a digital drug-delivery strategy, 69% of respondents cited the drive to improve patient engagement as one of the factors driving their organizations’ interest in drug-delivery solutions.
However, to optimize the benefits of remote healthcare, engineers need to design wearables that encourage regular use by addressing durability and reliability requirements and also providing both patient comfort and cost-effective development.